SEC Tracker
Get the app

Vistagen Therapeutics VTGN

VistaGen Therapeutics, Inc. issued a press release

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Earnings release
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Vistagen Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Eledon Pharmaceuticals ELDN public float $145M, Jun 30, 2025
  2. Puma Biotechnology PBYI public float $145M, Jun 30, 2025
  3. Neurogene NGNE public float $146M, Jun 30, 2025
  4. Forte Biosciences FBRX public float $157M, Jun 30, 2025
  5. Enanta Pharmaceuticals ENTA public float $111M, Mar 31, 2025, over 18 months old